Neural and pharmacological determinants of erection

International Journal of Impotence Research

Volumn 10, Issue SUPPL. 2, 1998, Pages

  Heaton, Jpw ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Classification; Erectile function; Erection; Neural determinants; Treatment

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; APOMORPHINE; CALCITONIN GENE RELATED PEPTIDE; CENTRAL STIMULANT AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM CHANNEL STIMULATING AGENT; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA; TRAZODONE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASODILATOR AGENT;

CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; IMPOTENCE; MALE; PENIS ERECTION; PRIORITY JOURNAL; SMOOTH MUSCLE;

HUMANS; MALE; PENILE ERECTION;

EID: 0031805667     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Heaton JPW, Adams MA, Morales A. A therapeutic taxonomy of treatments for erectile dysfunction: An evolutionary imperative. Int J Imp Res 1997; 9(3): 115-123.
2. Adams MA et al. Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems. Int J Imp Res 1997; 9(2): 85-92.